Echocardiographic features of patients with paroxysmal atrial fibrillation

International Journal of Cardiovascular Imaging

Volumn 24, Issue 2, 2008, Pages 159-163

  Colkesen, Yucel ^a   Acil, Tayfun ^a   Demircan, Senol ^a   Sezgin, Alpay T ^a   Ozin, Bulent ^a   Muderrisoglu, Haldun ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Echocardiography; Left atrium; Paroxysmal atrial fibrillation

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; WARFARIN;

ADULT; AGE DETERMINATION; AGED; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; DATA COLLECTION METHOD; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PALPITATION; HOLTER MONITORING; HUMAN; HYPERTENSION; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PREVALENCE; PROGNOSIS; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 38549102629     PISSN: 15695794     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10554-007-9247-3     Document Type: Article

References (14)

1. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S (2006) Task Force on Practice Guidelines, American College of Cardiology/American Heart Association; Committee for Practice Guidelines, European Society of Cardiology; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for the management of patients with AF-executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J 27(16):1979-2030
2. Allessie MA, Boyden PA, Camm AJ, Kleber AG, Lab MJ, Legato MJ, Rosen MR, Schwartz PJ, Spooner PM, van Wagoner DR, Waldo AL (2001) Pathophysiology and prevention of atrial fibrillation. Circulation 103(5):769-777
3. Kannel WB, Wolf PA, Benjamin EJ, et al (1998) Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 82:2N-9N
4. Chung MK, Burkhardt JD, Klein AL (2005) Strategies for stroke prevention in atrial fibrillation. Heart Rhythm 2(1):103-106
5. Tang RB, Dong JZ, Liu XP, Ma CS (2006) Inflammation and atrial fibrillation: Is Chlamydia pneumoniae a candidate pathogen of atrial fibrillation? Med Hypotheses 67(3):462-466
6. Boos CJ, Anderson RA, Lip GY (2006) Is atrial fibrillation an inflammatory disorder?. Eur Heart J 27:136-149
7. Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 48(3):e1-e148
8. Lévy S (2000) C lassification system of atrial fibrillation. Curr Opin Cardiol 15:54-57
9. Vaturi M, Sagie A, Shapira Y, Feldman A, Fink N, Strasberg B, Adler Y (2001) Impact of atrial fibrillation on clinical status, atrial size and hemodynamics in patients after mitral valve replacement. J Heart Valve Dis 10(6):763-766
10. Hagens VE, van Veldhuisen DJ, Kamp O, Rienstra M, Bosker HA, Veeger NJ, Tijssen JG, Crijns HJ, van Gelder IC (2005) RAte Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. Effect of rate and rhythm control on left ventricular function and cardiac dimensions in patients with persistent atrial fibrillation: results from the RAte Control versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) study. Heart Rhythm 2(1):19-24
11. Olshansky B, Heller EN, Mitchell LB, Chandler M, Slater W, Green M, Brodsky M, Barrell P, Greene HL (2005) Are transthoracic echocardiographic parameters associated with atrial fibrillation recurrence or stroke? Results from the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study. J Am Coll Cardiol 45(12):2026-2033
12. Wozakowska-Ka plon B (2005) Changes in left atrial size in patients with persistent atrial fibrillation: A prospective echocardiographic study with a 5-year follow-up period. Int J Cardiol 101(1):47-52
13. Volgman AS, Soble JS, Neumann A, Mukhtar KN, Iftikhar F, Vallesteros A, Liebson PR (1996) Effect of left atrial size on recurrence of atrial fibrillation after electrical cardioversion: Atrial dimension versus volume. Am J Card Imaging 10(4):261-265
14. Barbier P, Alioto G, Guazzi MD (1994) Left atrial function and ventricular filling in hypertensive patients with paroxysmal atrial fibrillation. J Am Coll Cardiol 24(1):165-170